Enamelon (ENML) - Does anyone follow this?

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech
Enamelon (ENML) - Does anyone follow this?

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
863	9	0	ENML

Emcee: Brent	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
338	You have a point. I wonder why the Church and Dwight guys would leave presumabl	michael d kugler	-	12/7/1997
337	Ask yourself why the majors passed on buying the patent, and Fox was able to pi	Mama Bear	-	12/7/1997
336	Just curious why you think this is a worthless security. The product does have	michael d kugler	-	12/7/1997
335	<<<The nationwide rollout is still scheduled for Q-1 '98, right?&	Greg B.	-	12/7/1997
334	>>>Now that Enamelon has 820,000 shares sold short (as of November 15)	Mama Bear	-	12/4/1997
333	It appears that there is going to be a need for some positive news before this	michael d kugler	-	12/4/1997
332	Enamelon's recent decline seems to be explained by the doubling of short sa	Greg B.	-	11/30/1997
331	YONKERS, N.Y., Nov. 25 /PRNewswire/ -- Enamelon, Inc. (Nasdaq: ENML), which i	Mama Bear	-	11/25/1997
330	Anyone planning to attend the Greater New York Dental Convention? The company	Greg B.	-	11/25/1997
329	Calls to Pittsfield, MA dental offices area revealed interesting results. <i	Greg B.	-	11/11/1997
328	For the record, I did not intend to imply that Enamelon would use coupons as a	Greg B.	-	11/7/1997
327	I wonder how to take some of these things: "Test marketing results for	Greg B.	-	11/7/1997
326	John, It wouldn't take much market share for this company to make money, a	michael d kugler	-	11/6/1997
325	I wonder how to take some of these things: <i> Test marketing results	Q.	-	11/6/1997
324	YONKERS, N.Y., Nov. 6 /PRNewswire/ -- Enamelon, Inc. (NASDAQ:ENML), which i	Q.	-	11/6/1997
323	Indeed, it is more Fox hype. But there are examples of company owners who hype	Greg B.	-	11/6/1997
322	Perhaps Enamelon thinks there are enough investors out there that believe the c	Warren	-	11/5/1997
321	Just another Fox hype attempt. He took news that is not good (pre- announcement	Q.	-	11/5/1997
320	ENML is taking off today. Why??	Mel Spivak	-	11/5/1997
319	The offering was completed last week, with net proceeds of "approximately	Greg B.	-	10/31/1997
318	Excellent insight! Clinical efficacy requires years of testing for caries claim	Warren	-	10/30/1997
317	Clinical trial data on efficacy isn't something that comes out overnight. T	Q.	-	10/30/1997
316	Discussion about marketing claims raises this question: are they collecting da	David Neal	-	10/29/1997
315	I don't doubt the advertising of the product to retail consumers meets FDA	Q.	-	10/29/1997
314	Does anyone believe that Enamelon is currently NOT consistent with the Monogra	Greg B.	-	10/28/1997

Go to reply# or date (mm/dd/yy):